Emkay Global Gets Listing Approval for 300k Shares

Date: 13th November, 2026

The company received in-principle listing approvals from National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) for 300,000 equity shares issued to Mr. Prakash Kacholia, one of the Promoters of the Company
The shares were allotted through conversion of equivalent warrants issued on a preferential basis

50,000 shares allotted on 21st August, 2026 (NSE Reference: NSE/LIST/57392, BSE Reference: LOD/PREF/RB/FIP/1097/2026-27)
150,000 shares allotted on 9th September, 2026 (NSE Reference: NSE/LIST/57755, BSE Reference: LOD/PREF/PB/FIP/1097/2026-2027)
100,000 shares allotted on 21st September, 2026 (NSE Reference: NSE/LIST/57806, BSE Reference: LOD/PREF/SS/FIP/1096/2026-2027)
Total: 300,000 equity shares of ₹10 each issued at premium of ₹229.50 per share

Trading approval will be granted only after the company files listing approval from NSE (if applicable)
Company must provide confirmation letters from NSDL/CDSL about crediting the shares to respective beneficiary accounts
Company must provide confirmation letters from NSDL/CDSL about lock-in of pre-preferential holding (if applicable)
Company must apply for trading approval within seven working days from date of grant of listing approval per SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023

Company must ensure compliance with Regulation 167 of SEBI (ICDR) Regulations
If shareholding change exceeds 2% of total paid-up share capital, company shall file shareholding pattern in XBRL mode as required under Regulation 31(1)(c) of SEBI LODR Regulations, 2015

Distinctive numbers for shares: 27625581 to 27675580 (50,000 shares), 27675581 to 27825580 (150,000 shares), 27825581 to 27925580 (100,000 shares)
The exchanges reserve the right to withdraw in-principle approval if information submitted is found incomplete/incorrect/misleading/false or in contravention of regulations